Want to see AIXC full AI Analyst Report?
AIXC Stock Chart & Stats
$0.78
-$0.06(-6.92%)
At close: 4:00 PM EDT
$0.78
-$0.06(-6.92%)
Day’s Range― - ―
52-Week Range$0.59 - $8.81
Previous Close$0.74
Volume26.65K
Average Volume (3M)2.51M
Market Cap
$14.09M
Enterprise Value$28.81
Total Cash (Recent Filing)$577.33K
Total Debt (Recent Filing)$39.56K
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.44
Shares Outstanding20,234,993
10 Day Avg. Volume502,358
30 Day Avg. Volume2,513,026
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.20
Price to Sales (P/S)0.00
P/FCF Ratio-0.24
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageMinimal debt limits interest obligations and provides some balance-sheet flexibility during the robotics transition. However, this advantage is meaningful only if the company can stabilize operations and reduce its dependence on external funding.
Asset-Light Robotics ModelUsing partner-owned and previously sold robots could let RoboShare expand supply without purchasing a large fleet. This lowers capital intensity and may improve scalability, asset utilization, and the economics of entering additional markets.
Commercial Robotics ProgressThe launch and first paid order move RoboShare beyond development into live commercial operations. Sustained repeat demand and viable order economics could establish an initial revenue base and validate the company’s physical-AI strategy.
Bears Say
Absent Revenue BaseThe lack of recurring revenue leaves the business model unproven and makes future funding dependent on successful pilot execution. Delays, weak utilization, or poor pricing could prevent RoboShare from supporting the company’s cost structure.
Severe Liquidity And Cash BurnVery limited cash relative to ongoing operating needs creates substantial financing and going-concern risk. Restricted liquidity may slow the Los Angeles pilot, constrain product investment, and force reliance on equity funding before operations become self-sustaining.
Persistent Losses And Treasury RiskLarge recurring losses and negative operating cash flow indicate that cost reductions have not yet produced a sustainable business. The impaired digital-asset treasury adds earnings volatility and reduces financial resources available for robotics commercialization.
AIxCrypto Holdings News
AIXC FAQ
What was AIxCrypto Holdings’s price range in the past 12 months?
AIxCrypto Holdings lowest stock price was $0.59 and its highest was $8.81 in the past 12 months.
What is AIxCrypto Holdings’s market cap?
AIxCrypto Holdings’s market cap is $14.09M.
When is AIxCrypto Holdings’s upcoming earnings report date?
AIxCrypto Holdings’s upcoming earnings report date is Apr 01, 2027 which is in 208 days.
How were AIxCrypto Holdings’s earnings last quarter?
AIxCrypto Holdings released its earnings results on Aug 07, 2026. The company reported -$0.206 earnings per share for the quarter.
Is AIxCrypto Holdings overvalued?
According to Wall Street analysts AIxCrypto Holdings’s price is currently Overvalued.
Does AIxCrypto Holdings pay dividends?
AIxCrypto Holdings does not currently pay dividends.
What is AIxCrypto Holdings’s EPS estimate?
AIxCrypto Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AIxCrypto Holdings have?
AIxCrypto Holdings has 20,234,993 shares outstanding.
What happened to AIxCrypto Holdings’s price movement after its last earnings report?
AIxCrypto Holdings reported an EPS of -$0.206 in its last earnings report. Following the earnings report the stock price went down -4.015%.
Which hedge fund is a major shareholder of AIxCrypto Holdings?
Currently, no hedge funds are holding shares in AIXC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AIxCrypto Holdings
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
AIXC Company Deck
AIXC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Negative
The call highlighted meaningful operational progress: the public launch of the RoboShare marketplace, an LA pilot targeted to begin in August, an asset-light second-life strategy for robots, sequential cost reductions and internal AI Agent testing. However, the company faces material near-term challenges: constrained liquidity with only $577K cash, large unrealized digital-asset losses, significant YTD cash burn and no material recognized revenue yet (revenues contingent on pilot execution). Year-over-year operating expense increases and a larger quarterly net loss versus the prior year further weigh on the outlook. While management has taken steps to reduce expenses and retain share count, the combination of limited cash runway and deferred strategic initiatives creates significant execution risk.View all AIXC earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.12% Mutual Funds
<0.01% Other Institutional Investors
98.66% Public Companies and
Individual Investors